Navigation Links
R-Tech Ueno Completes Phase 2a Clinical Study of RK-023 to Treat Androgenetic Alopecia
Date:1/24/2011

ima, MD, PhD, provided the following comments: "RK-023 has been developed as an anti-aging or a lifestyle drug that is one of the areas on research and development in R-Tech Ueno. I am very pleased to obtain the favorable results in safety assessment and in efficacy of global photo assessment. It is estimated that the global market size of drugs for androgenetic alopecia is approximately one billion US dollars. RK-023 is an important drug of our pipelines to develop our business. For the future we will facilitate this project to obtain approval more quickly with a view to the possibility of tie-up with domestic and foreign partners. RK-023 will improve the quality of life (QOL) for androgenetic alopecia patients."

Note 1) Androgenetic alopecia, which is male-pattern alopecia, is a gradually progressive hair-thinning and alopecic disease with replacement of thick long hair by thin, short and soft hair without hair regeneration localized in the parietal to the frontal region under the effect of androgenic hormone after puberty, finally leading to atrophy in the hair follicles and reduction in the number of hair. About 12 million males are affected in Japan.

Note 2) Double-blind is a study method usually on human subjects in an attempt to eliminate subjective bias on the part of both experimental subjects and experimenters.

Note 3) Study drug without medical agent

Note 4) Phototrichogram is a noninvasive technique that analyzes hair density, hair diameter and a hair growth rate. A magnified photograph on a scalp hair cut area is analyzed.

Note 5) Anagen hair is defined as hair with a growth rate of 0.2 mm or more per day through phototrichogram. Anagen is the phase during which hair grows. Decrease of an anagen hair rate represents the progression of androgenetic alopecia.

About R-Tech Ueno, Ltd.

R-Tech Ueno is a bio venture company established in September 1989 for the purpose of R&D and marketing of drugs. Under
'/>"/>

SOURCE R-Tech Ueno, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
2. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
3. R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
(Date:8/28/2014)... Telik, Inc. (OTCQB: TELK), a clinical ... MabVax Therapeutics, Inc. on July 8, 2014, announced ... the development of its lead antibody program designated ... Company,s internally developed antibody discovery platform.  These preclinical ... based therapeutic and diagnostic products based on this ...
(Date:8/28/2014)... 2014  Rx Safes, Inc., the manufacturer of fingerprint ... waging a new war on drugs to reduce prescription ... More than 2,500 children a day experiment with ... are easily accessed from unsecured medicine cabinets, closets and drawers. ... streets, Rx Safes will address the new age drug ...
Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4Rx Safes, Inc. Announces New War On Drugs 2
... Study of Zalutumumab in Combination, With Radiotherapy ... COPENHAGEN, June 24 Genmab A/S (OMX: GEN),announced ... zalutumumab,(HuMax-EGFr(TM)) in combination with radiotherapy for the treatment of,advanced ... maximum of 36,patients who are ineligible for platinum based ...
... New Recommendations Address Presurgery and Pediatric Dilemmas, ... evidence-based guidelines,address the prevention and management of ... related to the routine use of,preventive therapies. ... issue of CHEST,the peer-reviewed journal of the ...
Cached Medicine Technology:Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 2Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 3Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 2Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 3Thrombosis Guidelines Emphasize Difficult Choices for Pregnant Women 4
(Date:8/28/2014)... technology advances, science has become increasingly about datahow ... The creation of key databases to analyze and ... bioinformatics , or the collection, classification, storage, and ... and software. The tools and methods used in ... fields such as molecular genetics and genomics. But, ...
(Date:8/28/2014)... FL (PRWEB) August 28, 2014 Following the ... July 21, the FDA issued a warning ... word about this harmful substance that is readily available to ... In May, high school senior Logan Stiner died from an ... of the substance, leading the FDA to issue a safety ...
(Date:8/28/2014)... place glue directly on the nerve stumps, but this ... allows glue to easily invade the nerve ends. Ordinarily, ... insert the nerve ends into the conduit because the ... Liang and co-workers from the General Hospital of Chinese ... and defined the best parameters for its use through ...
(Date:8/28/2014)... and over who identify themselves as ,old, feel worse ... they have lower value than younger age groups. , ... titled ,Being old and ill, across different countries: social ... data from the European Social Survey. Respondents, who were ... their health., The researchers found that those living in ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Canadian Linen ... company in North America, today announced the launch of ... makes doing business with Canadian Linen even easier and ... customers to access account information online and better communicate ... portal include the ability to:, , ...
Breaking Medicine News(10 mins):Health News:Together, humans and computers can figure out the plant world 2Health News:Together, humans and computers can figure out the plant world 3Health News:FDA Issues Safety Advisory for Caffeine Powders 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 3
... of Texas Health Science Center at Houston say one organism ... causes colic, inconsolable crying in an otherwise healthy baby. ... that comes through the door," said J. Marc Rhoads, M.D., ... at Houston, which is part of the UT Health Science ...
... , , , , ... in June, Adecco USA continues to see job opportunities for qualified professionals ... unemployment rate is over 6%, Adecco USA currently has demand for 100 ... talent for today. , , Over ...
... , , SAN FRANCISCO, July ... for the Cure, one of over 100 Affiliates nationwide dedicated to putting ... million dollars to support Bay Area breast health education and breast cancer ... Komen San Francisco Bay Area Affiliate,s local fundraising efforts, such ...
... WASHINGTON, July 24 After reviewing scientific studies of the ... of Sciences has determined there is "limited or suggestive evidence" of ... to Agent Orange. , , "We ... conclusions," said John Rowan, National President of Vietnam Veterans of America ...
... of bark with right canine expression, researcher says , FRIDAY, ... new study suggests that 6-month-old babies know the answer. , ... out that an aggressive bark goes with an angry-looking dog. ... feelings in a different way. , The babies managed to ...
... July 24 Heska Corporation (Nasdaq: HSKA ) announces the following Webcast: , ... What: Heska Corporation Invites You to Join Its Second Quarter 2009, ... the Web, When: Monday, August 10, @ 9:00 a.m. (MDT), ... the, front page of ...
Cached Medicine News:Health News:Pinpointing cause of colic: UT Houston researchers identify organism 2Health News:Wanted: Oklahoma City Licensed Pharmacy Technicians 2Health News:San Francisco Bay Area Affiliate of the Susan G. Komen for the Cure Funds Over $1.2 Million This Year to Community Outreach Programs 2Health News:San Francisco Bay Area Affiliate of the Susan G. Komen for the Cure Funds Over $1.2 Million This Year to Community Outreach Programs 3Health News:San Francisco Bay Area Affiliate of the Susan G. Komen for the Cure Funds Over $1.2 Million This Year to Community Outreach Programs 4Health News:Babies Can Comprehend 'Canine' Language 2Health News:Webcast Alert: Heska Announces Second Quarter 2009 Earnings Conference Call Webcast 2
... contact lenses used for corneal refractive therapy, ... The patient wears the lenses overnight while ... the day, nearsightedness is corrected or greatly ... contact lenses apply slight pressure to the ...
MDI will work with your facility to determine the best interim lab to fit your needs and your site....
... currently maintains a large number of mobile, ... in its rental fleet. The labs are ... to several years. The Cath Lab Leasing ... while replacing or upgrading existing equipment, initiating ...
... holmium laser combines excellent cutting, ablation ... bloodless procedures. It is also extremely ... bladder stones of all compositions, making ... Because its laser light is transmitted ...
Medicine Products: